Your Article Summary
See Latest ArticlesRegulatory Properties of Copolymer I in Th17 Differentiation by Altering STAT3 Phosphorylation
Journal of Immunology, 06/23/09
Chen C et al. - The study revealed the differential regulatory roles and the novel mechanism of action of COP-I chiefly responsible for its treatment efficacy in experimental autoimmune encephalomyelitis and multiple sclerosis.
Today in Neurologic/Ophthalmic...keeping you current
Receive free subspecialty "5-minute updates" via email
The effects of bilastine compared with cetirizine, fexofenadine, and placebo on allergen-induced nasal and ocular symptoms in patients exposed to aeroallergen in the Vienna Challenge Chamber
Inflammation Research, 12/07/09
Th1, Th17, and Th9 Effector Cells Induce Experimental Autoimmune Encephalomyelitis with Different Pathological Phenotypes
Journal of Immunology, 12/07/09
Retinal astrocytes respond to IL-17 differently than retinal pigment epithelial cells
Journal of Leukocyte Biology, 12/04/09
Today in Rheumatic/Autoimmune...keeping you current
Receive free subspecialty "5-minute updates" via email
Inhibition of clonal expansion by Foxp3 expression as a mechanism of controlled T-cell responses and autoimmune disease
European Journal of Immunology, 12/07/09
Th1, Th17, and Th9 Effector Cells Induce Experimental Autoimmune Encephalomyelitis with Different Pathological Phenotypes
Journal of Immunology, 12/07/09
Vasculitis
Journal of Allergy and Clinical Immunology, 12/04/09